Your browser doesn't support javascript.
loading
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors.
Simonoff, Emily; Mowlem, Florence; Pearson, Oliver; Anagnostou, Evdokia; Donnelly, Craig; Hollander, Eric; King, Bryan H; McCracken, James T; Scahill, Lawrence; Sikich, Linmarie; Pickles, Andrew.
Afiliación
  • Simonoff E; Department of Child & Adolescent Psychiatry and Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
  • Mowlem F; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
  • Pearson O; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
  • Anagnostou E; Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada.
  • Donnelly C; Department of Pediatrics, University of Toronto, Toronto, Canada.
  • Hollander E; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • King BH; Autism and Obsessive Compulsive Spectrum Program, Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, New York, USA.
  • McCracken JT; Department of Psychiatry, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
  • Scahill L; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Sikich L; Department of Pediatrics, Marcus Autism Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Pickles A; Department of Psychiatry, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, North Carolina, USA.
J Child Adolesc Psychopharmacol ; 32(4): 233-241, 2022 05.
Article en En | MEDLINE | ID: mdl-35501967
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citalopram / Trastorno del Espectro Autista Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Child Adolesc Psychopharmacol Asunto de la revista: PEDIATRIA / PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citalopram / Trastorno del Espectro Autista Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Child Adolesc Psychopharmacol Asunto de la revista: PEDIATRIA / PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos